Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Public ClinicalTrials.gov record NCT03126786. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to evaluate the safety and efficacy of suprachoroidal CLS-TA used with intravitreal aflibercept in subjects with DME.
Study identification
- NCT ID
- NCT03126786
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 71 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 11, 2017 (Actual)
- Primary completion
- Apr 17, 2018 (Actual)
- Completion
- Apr 17, 2018 (Actual)
- Last update posted
- May 13, 2021
2017 – 2018
United States locations
- U.S. sites
- 29
- U.S. states
- 12
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Consultants of Arizona and Retinal Research Institute | Phoenix | Arizona | 85014-2709 | — |
| Retina Centers, PC | Tucson | Arizona | 85704 | — |
| California Retina Consultants | Bakersfield | California | 93309 | — |
| Retina Vitreous Medical Group Clinical Research | Beverly Hills | California | 90211-1841 | — |
| Northern California Retina Vitreous Associates Medical Group, Inc. | Mountain View | California | 94040 | — |
| Retina Institute of California | Palm Desert | California | 92260 | — |
| Retina Consultants San Diego | Poway | California | 92064-2526 | — |
| MedEye Associates | Miami | Florida | 33143-5188 | — |
| Retina Specialty Institute | Pensacola | Florida | 32503 | — |
| Sarasota Retina Institute | Sarasota | Florida | 34239 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880 | — |
| Emory Eye Center | Augusta | Georgia | 30909-6440 | — |
| Marietta Eye Clinic | Marietta | Georgia | 30060 | — |
| Midwest Eye Institute | Indianapolis | Indiana | 46290 | — |
| Retina and Vitrous Associates of Kentucky | Lexington | Kentucky | 40509 | — |
| The Johns Hopkins Wilmer Eye Institute | Baltimore | Maryland | 21287 | — |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740-5940 | — |
| Retina Associates of NJ | Teaneck | New Jersey | 07666 | — |
| Western Carolina Retinal Associates | Asheville | North Carolina | 28803 | — |
| Oregon Retina Institute | Medford | Oregon | 97504 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701-7374 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606-1224 | — |
| Texas Retina Associates-Arlington | Arlington | Texas | 76012-2505 | — |
| Austin Retina Associates | Austin | Texas | 78705 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| Valley Retina Institute, P.A. | McAllen | Texas | 78503 | — |
| Valley Retina Institute | McAllen | Texas | 78503 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240-1502 | — |
| Retina Consultants of Houston | The Woodlands | Texas | 77384 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03126786, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2021 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03126786 live on ClinicalTrials.gov.